Site Search

I’m a wife, mother of 2: and a 6-year Colon and Breast Cancer Survivor.  My cancer journey began in July 2015. After delaying my Mammogram screening and Colonoscopy ... Cancer; the two were unrelated. I’d been healthy, so I thought I could roll the dice and go without my regular screenings because of the cost. Boy, I was wrong. The Affordable Care Act saved my life. While in treatment, I vowed to advocate for other cancer patients and their ... the Editor opposing the repeal of the Affordable Care Act in the Charlotte Observer. A few months later, fate, in a call from Ray Riordan (ACS CAN Grassroots Manager 2017), set me off on the road of Advocacy as an American Cancer Society Cancer Action Network Ambassador Constituent Team ...

... proposal to roll back important Medicaid coverage for biomarker testing.  State lawmakers must reject Governor Hochul’s proposed rollback of biomarker testing access for Medicaid patients. Biomarker testing saves lives and reduces long-term health care spending. The 2023 law, passed ... jeopardizing coverage for millions. This proposal is short-sighted for the budget and will result in worse health outcomes.  Please join ACS CAN in calling on state lawmakers to preserve Medicaid patients’ access to biomarker testing.   Background Research shows that ... biomarker testing for all patients who need it. This is a shortsighted effort to save money that hurts patients – and could potentially cost Medicaid more. As the state grapples with federal funding cuts, it is more important than ever to spend Medicaid dollars efficiently – and ...

Breast Cancer in the United States Breast cancer is the second most commonly diagnosed cancer and the second-leading cause of cancer death in women. In 2018, an estimated 266,120 women will be diagnosed with invasive breast cancer, and approximately 40,920 women are ... women at risk. Nearly all cervical cancers are preventable. Regular screening – using the Pap and human papillomavirus (HPV) DNA tests – can detect precancerous lesions early when survival rates are the highest. Increased utilization of the Pap and HPV DNA test has resulted in a ... cancer screenings for women by requiring private insurers, Medicare, and Medicaid expansion programs to cover routine preventive services at no cost to the patient. However, millions of underinsured and uninsured women across the country still do not have access to these lifesaving ...

Welcome!  Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more Oklahomans can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, disease or abnormal function that can be measured in blood, tissue or bodily fluid.  Biomarker testing is the analysis of a patient’s tissue, blood or other biospecimen for the presence of a biomarker.   Policy action needed to ensure more Oklahomans benefit. Not ...